MedWatch

Entrepreneur left Novo Nordisk to produce take-home sperm tests - aims for DKK 50 million in three years

A good job in Novo Nordisk did not hold back Morten G. Ulsted, age 33, when he got the opportunity to co-found medtech company Exseed Health. The firm is about to launch a product to test men's sperm quality with a smartphone, and the entrepreneur aims for a revenue of DKK 50 million (USD 7.63 million) within three years.

Foto: PR, Exseed Health

The fertility rate in the West is decreasing rapidly, and Denmark is no exception. According to the Danish Health Authority, one in five Danish couples are infertile, and today every twelfth child is conceived after fertility treatment.

For approximately half of the interfile couples, the inability to become pregnant is male related. During the past 40 years, Western mens' sperm quality has decreased by 50 percent, and almost 40 percent of Danish men have such a bad sperm quality that it aggravates their chances of becoming a parent.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier